Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
An update from BONESUPPORT HOLDING AB ( (SE:BONEX) ) is now available.
BONESUPPORT has announced a significant leadership transition, with current CEO Emil Billbäck stepping down to become a Senior Advisor, and Torbjörn Sköld taking over as CEO effective September 1, 2025. This change is expected to leverage Sköld’s extensive experience in MedTech and orthopedics to further enhance the company’s growth and market position. The transition reflects the company’s strategic focus on maintaining its trajectory as a fast-growing and innovative leader in the orthobiologics sector.
More about BONESUPPORT HOLDING AB
BONESUPPORT is a prominent player in the orthobiologics industry, specializing in the development and commercialization of innovative injectable bio-ceramic bone graft substitutes. These products are designed to remodel into the patient’s own bone and have the capability of eluting drugs. The company is based in Lund, Sweden, and reported net sales of SEK 899 million in 2024.
YTD Price Performance: -20.24%
Average Trading Volume: 361
Technical Sentiment Signal: Sell
Current Market Cap: $2.16B
See more insights into BONEX stock on TipRanks’ Stock Analysis page.